Introduction

24-Methylenecycloartanyl ferulate (24-MCF), a gamma oryzanol (γ-oryzanol) compound,
is a non-toxic dietary compound that exhibits important pharmacological activities, such as anticholesterol [1, 2] , anti-platelet aggregation [3] , and anti-tumor properties [4, 5, 6] . Our previous studies showed that 24-MCF-induced peroxisome proliferator-activated receptor-gamma 2 (PPAR-γ2) activation increased parvin-β expression, leading to the inhibition of oncogenic integrin-linked kinase that is associated with tumor angiogenesis signaling in MCF7 cells [4] .
PPAR represents a nuclear hormone receptor superfamily of ligand-inducible transcription factors that regulate genes in various metabolic processes. The PPAR family comprises three isoforms: PPARα, PPARβ/δ, and PPARγ [7] . Activated PPARα regulates genes involved in the β-oxidation pathway [8, 9] , PPARβ/δ enhances glucose metabolism, and activation of PPARγ causes insulin sensitization and enhances glucose metabolism [10] . Three different isoforms of PPARγ have been identified and were generated as a result of alternative splicing: PPARγ1, PPAR-γ2, and PPAR-γ3 [11] . PPAR-γ2 is expressed exclusively in adipose tissue and accelerates adipocyte differentiation [12] . A potential role for PPARγ in carcinogenesis was highlighted by the ability of the ligands to affect cellular proliferation and differentiation [13] . Because of its potent effects on the regulation of cell fate, PPARγ has attracted interest as a potential target for cancer therapy [7] . Furthermore, numerous studies have shown that PPARγ activation leads to the regulation of anti-and pro-angiogenic pathways [14, 15] .
Although several key components of the angiogenesis process and the angiogenic switch have been reported [17, 18, 19] , the complete underlying molecular mechanisms are not fully known. Previous studies showed that the promoter sequence of the pro-angiogenic factor VEGF contains a PPAR response element (PPRE) motif [16, 20] and demonstrated that PPARγ activation decreases pro-angiogenic VEGF [14, 15] . The PI3K/Akt/mTOR pathway also modulates the expressions of pro-angiogenic factors, such as VEGF and angiopoietins [21] .
Numerous inhibitors targeting the PI3K/Akt/mTOR pathway have been identified in plants and food sources [17, 22] , and these compounds have been shown to decrease VEGF secretion and angiogenesis [17, 22] . Although 24-MCF has recently been shown to possess anti-tumor properties [4, 5, 6] , its molecular mechanism is not fully understood and its potential effects on angiogenesis have remained largely unknown.
In this study, we hypothesized that PPAR-γ2 regulates 24-MCF-mediated angiogenesis.
We first examined whether angiogenesis-related genes identified by microarray in MCF-7 cells treated with 24-MCF are PPAR-γ2 target genes. We also evaluated whether 24-MCF treatment activates the Akt/mTOR pathway.
Materials and Methods
Materials
The rice bran compound 24-MCF was provided by the Korean National Institute of Crop Science (Jeollabuk-do, Korea). Each gene on the array Agilent Human Whole Genome 44K v2 chip was provided by E-Biogen Inc. (Seoul, Korea). Total RNA was extracted from human breast cancer MCF7 cells using a TRIzol reagent kit (Invitrogen, San Diego, CA) following the manufacturer's instructions. Antibodies against phospho-Akt (Ser 473), Akt, phospho-mTOR (Ser 2448), and mTOR were purchased from Cell Signaling Technology (Beverly, MA). Hypoxia-inducible factor (HIF)-1α, HIF-1β, PPAR-γ2, VEGF and β-actin antibodies were purchased from Santa Cruz (Santa Cruz, CA).
Cell culture
Human breast cancer MCF7 cells were cultured in Dulbecco's Modified Eagle's Medium (HyClone, Logan, UT) supplemented with 10% heat-inactivated fetal bovine serum (HyClone, Logan, UT), 100 U/ml penicillin, and 100 µg/ml streptomycin in 5% CO2 at 37°C. Human umbilical vein endothelial cells (HUVECs; Lonza, Walkersville, MD) were cultured in EBM-2 medium supplemented with EGM-2 Single Quots. EBM-2 and EGM-2 Single Quots were purchased from Cambrex Company (Lonza, Walkersville, MD).
Plasmid constructs
We collected the putative PPRE motifs using the GeneCards (www.genecards.org) and Dragon PPAR Response Element Spotter v.2.0 (www.cbrc.kaust.edu.sa/ppre/). To construct promoterreporter plasmids, promoter fragments containing PPRE motifs were amplified and ligated into the SacI and Hind III sites of the pGL3-Basic vector, which contains firefly luciferase coding sequences but lacks eukaryotic promoter or enhancer elements.
Oligonucleotides used in this experiment were as follows: VEGF (-913 to +1) were 5′-GCAC ATTGTCAGAGGGACACACTGTGGCCC-3′ (forward) and 5′-CTCTGTCCAGAGAC ACGCGCCCGCGGGGCA-3′ (reverse); LIF (-9032 to -8403) were 5′-AGGCGATGAC TGGGCAGCCCTCCGCAT-3′ (forward) and 5′-CTCCCAGCTGTGACAAAGATTCCCTGG-3′ (reverse); and HoxA7 (-1107 to +1) were 5′-GGATCCAGACGGGGAAGGCGCAGCATCTCT-3′ (forward) and 5′-GGGAGGAGACAGCCCAGCGCCCACCTGCCC-3′ (reverse).
Mutation of the PPRE motifs in the VEGF promoter, which abolishes the PPAR-γ2 binding site, was constructed by a 5-bp substitution (5′-GGAGAAGGCCAG aaGctt CTCCAGG, underlined).
Construction of pcDNA-human PPAR-γ2 (accession No. NM_015869) expression plasmid was described previously [4] . Plasmids were confirmed by DNA sequencing.
Microarray
Microarrays were generated and cRNA probes were hybridized using the Low RNA Input Linear Amplification Kit (Agilent Technology, Santa Clara, CA) according to the manufacturer's instructions. Labeled cRNA was purified on a cRNA Cleanup Module (Agilent Technology, Santa Clara, CA) according to the manufacturer's instructions. Fragmented cRNA was resuspended with 2× hybridization buffer and directly pipetted onto the assembled Human Oligo Microarray (44K; Agilent Technology). Arrays were hybridized at 65°C for 17 h using a hybridization oven (Agilent Technology, Santa Clara, CA). Hybridized microarrays were washed according to the manufacturer's protocol (Agilent Technology).
Data analysis
Hybridized images were scanned using a DNA microarray scanner (Agilent Technology, Santa Clara, CA) and quantified with Feature Extraction software (Agilent Technology). All data normalization and selection of genes whose expression changed were performed using GeneSpring GX 7.3 (Agilent Technology). The averages of normalized ratios were calculated by dividing the average of the normalized signal channel intensity by the average of the normalized control channel intensity. Functional annotation of genes was performed according to the Gene Ontology Consortium (http://www.geneontology.org/index.shtml) using Gene Spring GX 7.3.
Genes were classified based on searches performed by BioCarta (http://www.biocarta.com/), GenMAPP (http://www.genmapp.org/), DAVID (http://david.abcc.ncifcrf.gov/), and Medline (http://www.ncbi.nlm.nih.gov/).
Western blot analysis
Western blot analysis was performed according to a standard method as previously described [4] .
Protein samples (20 µg) were separated on a 4-12% NuPAGE gel (Invitrogen, San Diego, CA) and then transferred to a nitrocellulose membrane using standard procedures. The membrane was blotted with primary antibodies or anti-β-actin antibody as a control and analyzed using the Multi Gauge V3.1 program (Fujifilm Tokyo, Japan).
RNA isolation and quantitative reverse transcription (RT)-PCR analysis
Total RNA was isolated using TRIzol reagent (Invitrogen, San Diego, CA) according to the manufacturer's protocol. Total RNA (1 µg) was converted to cDNA using oligo-dT primer and AccuPower RT premix (Bioneer, Korea) in a 20 µl reaction. PCR reactions were performed using the AccuPower PCR Mix (Bioneer, Korea) and primers (see Table 1 for primer sequences).
PCR was performed at an annealing temperature of 55-58°C for 25-30 cycles. The amplified PCR products were run on a 2.0% agarose gel and visualized using ethidium bromide (Sigma, St.
Louis, MO). Twenty-four hours later, cells were incubated with a medium containing dimethyl sulfoxide (DMSO) or 24-MCF (25, 50, and 100 µM). After 24 h, both firefly and Renilla luciferase activities were quantified using a Dual-Luciferase Reporter Assay system (Promega, Madison, WI) according to the manufacturer's instructions. Relative luciferase activity was calculated as the ratio of firefly /Renilla activity. All experiments were performed in triplicate.
Quantification of VEGF protein
VEGF was quantified using the Quantikine human VEGF enzyme-linked immunosorbent assay (ELISA) kit (R&D Systems, Minneapolis, MN) according to the manufacturer's instructions.
Briefly, MCF7 cells were seeded in 12-well plates and cultured until 90% confluent. Cells were switched to fresh serum-free medium containing 24-MCF. After 12 h, the conditioned medium was collected and the number of cells in each well was counted. The secretion of VEGF in the conditioned medium (200 µl) was determined and normalized against the number of cells in the well. A serial dilution of human recombinant VEGF was performed in each assay to obtain a standard curve. All experiments were performed in triplicate.
Tube formation assays
Endothelial tube formation was assessed by an in vitro cell-based assay (Cayman Chemical, Ann Arbor, MI) in HUVECs according to the manufacturer's instructions. Phorbol 12-myristate 13-acetate (PMA) pretreatment enhanced the ability of HUVECs to organize into cell networking structure (termed tube formation). A suspension of HUVECs in medium was then seeded in 96-well plates coated with cell-based extracellular matrix gel at a density of 10 5 cells/ml and treated with 24-MCF in the presence of 1 µM PMA. After 12 h, tube formation was observed by calcein staining under an inverted fluorescence microscope (Olympus IX71, Tokyo, Japan).
Statistical analyses
All data were evaluated by a one-way analysis of variance (ANOVA). A P-value of < 0.05 was considered to be statistically significant.
Results
Gene expression profiles of 24-MCF-treated MCF7 cells
We 
Validation of microarray data using RT-PCR
From the functional annotation clustering analysis, we then selected 15 genes in the angiogenesis categorization that were differentially expressed. Genes with fold change > 2 are upregulated and genes with fold change < 0.5 are downregulated in the MCF7 cells treated with 24-MCF ( Figure   2A ). Table 2 provides further characterization of 10 of the 15 genes that were more strictly responsive to 24-MCF; literature search for these genes classified them as anti-and proangiogenesis related genes based on their reported functions. For validation of 10 genes that were differentially expressed among all genes in the angiogenesis category, we next analyzed expression levels of these genes using RT-PCR with the primers listed in Table 1 . These results showed that at 12 h after 24-MCF treatment, anti-angiogenesis-related genes (LIF, NPPB, PPAR-γ2, and EGR1 genes) were significantly upregulated, whereas pro-angiogenesis-related genes (HoxA7, L1Cam, MMP11, RHOT1, VEGF, and Pbx1 genes) were markedly downregulated in MCF7 cells ( Figure 2B ). Furthermore, these effects occurred in a dose- 
PPAR-γ2 modulates the promoter activity of angiogenesis-related genes via PPRE motif
We hypothesized that the PPAR-γ2 transcription factor is involved in regulating 24-MCFmediated angiogenesis. To determine whether PPAR-γ2 regulates the angiogenesis-related genes identified in the microarray, we performed luciferase assays using promoter sequences from three of the identified genes. We constructed luciferase reporter plasmids driven by promoter sequences from VEGF (-914/+1) and HoxA7 (-1107/+1), both known pro-angiogenic genes that were identified as downregulated genes in the microarray ( Figure 3A and 3B). We transfected the VEGF and HoxA7 reporter plasmids together with the pcDNA3-PPAR-γ2 expression plasmid or the vector plasmid (pcDNA3) into MCF7 cells and performed luciferase assays. As shown in Figures 3A and 3B , we observed that activation of the VEGF and HoxA7 promoter was significantly decreased in comparison with the control (p<0.05). To analyze whether the transcriptional regulation of the VEGF promoter by PPAR-γ2 is mediated by its interaction with the PPRE motif, we constructed a mutant VEGF reporter vector with a 5-bp substitution in the PPRE (GGGTCA to aaGctt). As shown in Figure 3A , the PPAR-γ2-mediated activation of the PPRE mutant vector was abolished compared with wild-type (p<0.05), indicating that the PPRE motif is critical for PPAR-γ2-mediated transcriptional induction of VEGF.
We also performed luciferase assays using the promoter sequence of LIF (-9032 / -8403), an anti-angiogenic gene that was identified as an upregulated gene in the microarray ( Figure 3E ).
We observed that the activation of the LIF reporter vector by PPAR-γ2 expression was significantly increased in comparison with the control (no PPAR-γ2 expression and DMSO) (p<0.05) ( Figure 3C ), indicating that PPAR-γ2 could be a key regulator of the anti-angiogenic balance in angiogenesis. Values represent as fold induction of the control. *p <0.05 compared with the control.
24-MCF inhibited VEGF activation and inhibited the Akt/mTOR pathway
Our previous study demonstrated that the 24-MCF compound inhibited Akt kinase activity [4] . VEGF secretion levels in the supernatant were determined in the presence or absence of 24-MCF using ELISA and normalized against the number of cells in the well. A serial dilution of human recombinant VEGF was performed in each assay to obtain a standard curve. All experiments were performed in triplicate. *p < 0.05 compared with DMSO control.
(C) HUVECs were kept in 1% FBS containing medium for 12 h. Tube formation on matrigel was performed using HUVECs treated with 1 µM phorbol-12-myristate-13-acetate (PMA), 24-MCF (25 or 100 µM) and/or JNJ-10198409 (1 µM) as indicated. Tube formation was observed by calcein staining under an inverted fluorescence microscope (Olympus IX71, Tokyo, Japan).
24-MCF inhibited tube formation in HUVECs
To determine whether 24-MCF treatment exhibits anti-angiogenic activity, we performed tube formation assays in HUVEC cells using an in vitro cell-based assay. 
Discussion
Angiogenesis is the formation of new blood vessels and is a hallmark of tumor development and metastasis [23] . In particular, PPARγ targets a set of genes that have a critical impact on numerous diseases including angiogenesis and cancer [24, 25] . PPARγ activation also inhibits angiogenesis by blocking ELR+CXC chemokine secretion, which is mediated through antagonizing NF-κB activation in non-small cell lung cancer (NSCLC) [26] . Our previous results
show that 24-MCF-induced PPAR-γ2 increases parvin-β expression, which inhibits oncogenic ILK signaling, anchorage-independent growth, and cell migration [4] . A recent study established
PPARs as a group of ligand-activated transcriptional regulators that sit at the intersection of genes and the dietary environment [27] . Thus, PPARγ has shown predominately anti-angiogenic properties in vitro and in animal models [27] . Therefore, some research has examined the PPARγ activating potential of a wide range of natural products originating from traditionally used medicinal plants and dietary sources [17] . The γ-oryzanol compound 24-MCF has been reported to have important pharmacological activities, including anti-tumor properties [4, 28] . It has nontoxicity and is used as a healthy food supplement [4] . Nonetheless, its mechanism is unclear. In addition, 24-MCF induced gene expression changes have not been fully recognized until now.
Here we identified differentially expressed genes in MCF7 cells treated with 24-MCF using a microarray technique. We found that the genes differentially expressed in response to 24-MCF treatment were involved in various cellular responses, including the inflammatory response, angiogenesis, aging, extracellular matrix, cell proliferation, immune response, cell death, and cell migration. Based on the clustering results, we selected the most significantly angiogenesisrelated genes, including five anti-angiogenesis-related genes that were upregulated (NPPB, LIF, PPAR-γ2 and EGR1 genes) and six pro-angiogenesis-related genes that were downregulated (HoxA7, L1Cam, MMP11, RHOT1, VEGF, and Pbx1 genes). Interestingly, a few tumor suppressor genes (e.g., LIF, NPPB, PPAR-γ2, and EGR1) and oncogenic genes (e.g. HoxA7,
L1cam, and MMP11) showed differences in expression upon 24-MCF treatment, implying that 24-MCF treatment can inhibit the activation of angiogenesis for tumor progression [29] .
Angiogenesis is tightly regulated at the molecular level [30] . The imbalance of pro-and anti-angiogenic signaling within tumors creates an abnormal vascular network that is characterized by dilated, tortuous and hyperpermeable vessels [30] . Based on our results, we
propose that 24-MCF induces PPAR-γ2 to function as an angiogenic switch that mediates the balance between pro-and anti-angiogenic molecular levels [ Figure 5 ]. We identified the presence of PPAR-γ2 binding regions in VEGF, LIF, and HoxA7 promoter sequences, and our luciferase assays showed PPAR-γ2 decreased activation of the promoters of VEGF and HoxA7, both known pro-angiogenic genes, while the activation of LIF promoter, an anti-angiogenic gene, PI3K/Akt/mTOR pathway also behaves as an angiogenesis inducer involved in VEGF expression [21] . Akt is a central signaling molecule in regulating cell survival, proliferation, tumor growth and angiogenesis [21] . 24-MCF treatment also affected the Akt/mTOR pathway and VEGF expression in MCF7 cells. These results are consistent with our previous results
showing that 24-MCF inhibited Akt kinase activity in a cell-free system and docking evidence using the X-ray crystal structure of human Akt protein (PDB ID: 3OCB) [4] . Our ELISA results
showed that VEGF secretion was decreased in MCF7 cells treated with 24-MCF. Based on previous studies that displayed PMA-induced angiogenesis is VEGF-dependent [33] , we analyzed the ability of HUVECs to undergo cell tube formation in response to 24-MCF treatment and found that PMA-induced tube formation of HUVEC cells was markedly attenuated by 24-MCF treatment. These results are consistent with previous results showing that VEGF can regulate all of the key steps of the angiogenic process, including proliferation, migration, and tube formation [34] . Thus, the Akt/mTOR pathway is considered very important for VEGF downstream signaling [35] . Our western blot analysis demonstrated that 24-MCF treatment reduced Akt/mTOR signaling ( Figure 4A ). Together this suggests a model by which VEGF secretion and tube formation is attenuated by 24-MCF by blocking the Akt signaling pathway.
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